Genaro M Vasquez

Genaro M. Vasquez serves as a key procurement professional within the Naval Medical Research Unit South (N44852), supporting the Department of Defense’s mission to enhance military medical readiness through applied scientific research. He manages acquisitions focused on tropical and infectious disease research, vector-borne threat mitigation, and field-deployable diagnostic systems. His work directly enables the agency’s laboratory and field operations by securing specialized scientific services, analytical instrumentation, and testing capabilities critical to expeditionary force protection. Vasquez handles a portfolio of research and development contracts, primarily in life sciences and analytical laboratory services, ensuring alignment with operational needs in high-risk, tropical environments. While specific contractor names are not publicly disclosed, Vasquez maintains a dynamic partnership ecosystem with firms specializing in biological threat detection, entomological surveillance technologies, and diagnostic assay development. He engages both large-tier scientific contractors and innovative small businesses capable of rapid prototyping and field validation of medical countermeasures. His procurement approach emphasizes technical rigor, rapid turnaround, and adaptability to emerging pathogen threats, fostering collaborative relationships with vendors possessing niche expertise in biosafety level 2 and 3 environments. Vasquez demonstrates a strong commitment to socioeconomic contracting, with 35% of his awards designated for 8(a) competed set-asides, reflecting a deliberate strategy to cultivate small business innovation in defense-relevant life sciences. His contracting patterns prioritize 8(a) firms capable of delivering specialized R&D and laboratory testing services, aligning with the agency’s need for agile, mission-focused vendors. While the majority of acquisitions remain open to all competitors, the consistent use of 8(a) set-asides underscores a strategic emphasis on building a resilient small business base in military medical innovation. His primary procurement focus lies in NAICS 541712 (R&D in life sciences) and 541380 (testing laboratories), with significant activity in analytical instrument manufacturing under 334516. He routinely acquires advanced diagnostic platforms, field-deployable PCR systems, vector monitoring equipment, and biocontainment-compatible lab services, demonstrating deep technical fluency in infectious disease research infrastructure and operational medical readiness.